Yesterday, March 3, 2016, 128 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $7.31 to $24,274,480.00.

Highlighted Stocks Traded by Insiders:

ExlService Holdings (EXLS) - FREE Research Report

Saltzman Nancy, who is EVP & Gen. Counsel/Corp. Sec'y at ExlService Holdings, sold 346 shares at $47.30 on March 3, 2016. Following this transaction, the EVP & Gen. Counsel/Corp. Sec'y owned 0 shares meaning that the stake was reduced by 100% with the 346-share transaction.

The shares most recently traded at $48.24, up $0.94, or 1.95% since the insider transaction. Historical insider transactions for ExlService Holdings go as follows:

  • 4-Week # shares sold: 881
  • 12-Week # shares sold: 881
  • 24-Week # shares sold: 115,454

The average volume for ExlService Holdings has been 264,700 shares per day over the past 30 days. ExlService Holdings has a market cap of $1.6 billion and is part of the services sector and diversified services industry. Shares are up 7.92% year-to-date as of the close of trading on Thursday.

ExlService Holdings, Inc. provides business process solutions, utilizing operations management, analytics, and technology primarily in the United States and the United Kingdom. It operates in two segments, Operations Management, and Analytics and Business Transformation. The company has a P/E ratio of 32.4. Currently, there are 8 analysts who rate ExlService Holdings a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EXLS - FREE

TheStreet Quant Ratings

rates ExlService Holdings as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and solid stock price performance. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full

ExlService Holdings Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Entellus Medical (ENTL) - FREE Research Report

Peterson Karen E, who is Officer at Entellus Medical, sold 5,000 shares at $16.00 on March 3, 2016. Following this transaction, the Officer owned 53,384 shares meaning that the stake was reduced by 8.56% with the 5,000-share transaction.

The shares most recently traded at $15.66, down $0.34, or 2.17% since the insider transaction. Historical insider transactions for Entellus Medical go as follows:

  • 4-Week # shares bought: 376,764
  • 4-Week # shares sold: 5,000
  • 12-Week # shares bought: 376,764
  • 12-Week # shares sold: 15,000
  • 24-Week # shares bought: 376,764
  • 24-Week # shares sold: 15,000

The average volume for Entellus Medical has been 48,500 shares per day over the past 30 days. Entellus Medical has a market cap of $301.3 million and is part of the health care sector and health services industry. Shares are down 5.1% year-to-date as of the close of trading on Thursday.

Entellus Medical, Inc., a medical technology company, focuses on the design, development, and commercialization of products for the minimally invasive treatment of patients suffering from chronic sinusitis. Currently, there are 3 analysts who rate Entellus Medical a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ENTL - FREE

TheStreet Quant Ratings

rates Entellus Medical as a

sell

. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share and deteriorating net income. Get the full

Entellus Medical Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Green Plains (GPRE) - FREE Research Report

Becker Todd A, who is President and CEO at Green Plains, sold 26,287 shares at $14.13 on March 3, 2016. Following this transaction, the President and CEO owned 642,056 shares meaning that the stake was reduced by 3.93% with the 26,287-share transaction.

The shares most recently traded at $15.20, up $1.07, or 7.04% since the insider transaction. Historical insider transactions for Green Plains go as follows:

  • 4-Week # shares bought: 500
  • 4-Week # shares sold: 4,871
  • 12-Week # shares bought: 500
  • 12-Week # shares sold: 4,871
  • 24-Week # shares bought: 500
  • 24-Week # shares sold: 4,871

The average volume for Green Plains has been 699,200 shares per day over the past 30 days. Green Plains has a market cap of $549.4 million and is part of the basic materials sector and chemicals industry. Shares are down 34.5% year-to-date as of the close of trading on Thursday.

Green Plains Inc. produces, markets, and distributes ethanol in the United States and internationally. The company operates through four segments: Ethanol Production; Agribusiness; Marketing and Distribution; and Partnership. The stock currently has a dividend yield of 3.36%. The company has a P/E ratio of 79.3. Currently, there are 3 analysts who rate Green Plains a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GPRE - FREE

TheStreet Quant Ratings

rates Green Plains as a

hold

. The company's strengths can be seen in multiple areas, such as its good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and poor profit margins. Get the full

Green Plains Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.